Skip to main content
Livermore
Livermore
ZHEN

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

ADAPY holding history

Adaptimmune Therapeutics PLC in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADAPY overviewAll 13F holders of ADAPYFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of ADAPY by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−426,714−100.0%Sold outHolders
Q2 2025426,714$102.3K<0.1%+5,422+1.3%AddedHolders
Q1 2025421,292$83.0K<0.1%+21,213+5.3%AddedHolders
Q4 2024400,079$215.5K<0.1%+3,287+0.8%AddedHolders
Q3 2024396,792$377.1K<0.1%+5,891+1.5%AddedHolders
Q2 2024390,901$381.1K<0.1%+78,363+25.1%AddedHolders
Q1 2024312,538$493.8K<0.1%+7,202+2.4%AddedHolders
Q4 2023305,336$242.1K<0.1%+6,235+2.1%AddedHolders
Q3 2023299,101$233.3K<0.1%+8,127+2.8%AddedHolders
Q2 2023290,974$269.2K<0.1%+6,233+2.2%AddedHolders
Q1 2023284,741$310.4K<0.1%+15,943+5.9%AddedHolders
Q4 2022268,798$392.4K<0.1%−40,500−13.1%ReducedHolders
Q3 2022309,298$332.0K<0.1%−57,227−15.6%ReducedHolders
Q2 2022366,525$623.0K<0.1%−274,095−42.8%ReducedHolders
Q1 2022640,620$1.32M<0.1%+25,627+4.2%AddedHolders
Q4 2021614,993$2.31M<0.1%+47,784+8.4%AddedHolders
Q3 2021567,209$2.94M<0.1%+307,627+118.5%AddedHolders
Q2 2021259,582$1.11M<0.1%−147,905−36.3%ReducedHolders
Q1 2021407,487$2.16M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.